@article{ref1,
title="Survival without peripheral neuropathy after massive acute arsenic poisoning: Treated by 2,3-dimercaptopropane-1-sulphonate",
journal="Journal of clinical pharmacy and therapeutics",
year="2017",
author="Lu, P.-h. and Tseng, J.-c. and Chen, C.-k. and Chen, C.-h.",
volume="42",
number="4",
pages="506-508",
abstract="WHAT IS KNOWN AND OBJECTIVE: Massive acute arsenic poisoning is rare yet potentially life-threatening. 2,3-dimercaptopropane-1-sulphonate (DMPS) appears to have the appropriate chelating property. However, clinical experience on the use of DMPS in massive arsenic poisoning is limited. CASE DESCRIPTION: A 37-year-old woman attempted suicide by ingesting 37.5 g of arsenic trioxide. DMPS was promptly initiated based on history and clinical symptoms. The patient recovered completely, with no complications or side effects of the therapy. WHAT IS NEW AND CONCLUSION: TDMPS is useful for the treatment of massive acute arsenic poisoning.<p /><p>Language: en</p>",
language="en",
issn="0269-4727",
doi="10.1111/jcpt.12538",
url="http://dx.doi.org/10.1111/jcpt.12538"
}